Gaurav Kaithwas

11PUBLICATIONS
5CO-AUTHORS
Molecular targetsCancer cell biologyComputational physiologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 19, 2025
Optimizing siRNA Therapeutics Targeting HIF-1α: Computational Design, Screening, and Molecular Dynamics Simulation Studies.

Neeraj Kumar Shrivastava, Pratibha Verma, Garima Singh

|Oct 19, 2024
A novel quinazoline derivative exhibits potent anticancer cytotoxicity via apoptosis and inhibition of angiogenesis in DMBA-induced mammary gland carcinoma.

Soniya Rani, Rimjhim Trivedi, Mohd Nazam Ansari

|May 10, 2024
Novel carbamodithioate regulates cellular hypoxia through chemical activation of prolyl hydroxylase-2 for breast cancer chemoprevention.

Shubham Rastogi, Mohd Nazam Ansari, Abdulaziz S Saeedan

|Mar 15, 2024
Novel furan chalcone modulates PHD-2 induction to impart antineoplastic effect in mammary gland carcinoma.

Shubham Rastogi, Mohd Nazam Ansari, Abdulaziz S Saeedan

|May 11, 2022
Rifaximin, a pregnane X receptor (PXR) activator regulates apoptosis in a murine model of breast cancer.

Swetlana Gautam, Priyanka Singh, Manjari Singh

Pageof 2